Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect strong support for the idea that giving patients choice in PTSD treatment leads to better adherence and results, with comments such as 'patients get the treatment they prefer' and 'improves outcomes.' The tone is optimistic and highlights the potential for this research to influence future clinical practices, demonstrating moderate engagement and perceived impact.
Most discussions highlight support for the findings that patient preference improves treatment outcomes, indicating general agreement.
The topic appears highly relevant and engaging, as multiple posts emphasize the significance of personalized treatment in PTSD therapy.
While some posts quote the research directly and mention specific effects, the overall depth of discussion remains moderate.
The posts suggest the research could influence treatment approaches and policy, but no indication of immediate widespread change is present.
@jonathanstea @tmarshallmph @somedocs Here’s a cleverly designed RCT showing that outcomes are better when patients receive the treatment they prefer, whether meds or therapy. https://t.co/UMdQrBgne0
Read Dr. Norah Feeny's, co-authored article "Doubly Randomized PTSD Preference Trial of Prolonged Exposure Versus Sertraline," published in the American Journal of Psychiatry! -@CWRUpsychsci https://t.co/lFTDlz2W1W @cwru @CWRUpsychsci https://t.co/6Nov1b595b
Alkaako uusi #tutkimusasetelma'kulttuuri? Potilaan oma preferenssi vaikuttaa lopputulokseen ja parantaa sitoutumista. Esimerkkinä #PTSD https://t.co/lS4pMY5qjs
@LLocock @jimgthornton @GillMoncrieff @Stroppybrunette @yvkoff @TomPettinger @SaraDonetto @KatsuyamaSarah @BerksMaternity @millihill @ProsserSnelling @LindAlliance @elizabethduff2 @DrSMcMullen @Marianfknight @MaryNewburn1 Just for fun - recent paper from a clinical field I’m more familiar with - patient preference predicted treatment response https://t.co/q9sUNCFBbP These are important issues to consider but they don’t, imo, mean trials should not be done.
@TedBonar @JonathanShedler @CarmenMcLeanPhD @PatriciaResick @sheila_rauch And here is my new fave study, which shows that trauma therapy (and meds) work better when patients get the treatment they prefer: https://t.co/UMdQrBxY5y /13
@sternentheater @spektrum_de @ABSG_DE @depr_liga Hier der Link zum @AmJPsychiatry: https://t.co/8StANWR0Yg
Executive Editor Michael Roy discusses with Lori A Zoellner PhD her research on how patient treatment preference affects PTSD treatment outcomes, emphasizing the importance of patient choice in enhancing adherence and…
@TedBonar @JonathanShedler @CarmenMcLeanPhD @PatriciaResick @sheila_rauch And here is my new fave study, which shows that trauma therapy (and meds) work better when patients get the treatment they prefer: https://t.co/UMdQrBxY5y /13
@jonathanstea @tmarshallmph @somedocs Here’s a cleverly designed RCT showing that outcomes are better when patients receive the treatment they prefer, whether meds or therapy. https://t.co/UMdQrBgne0
Alkaako uusi #tutkimusasetelma'kulttuuri? Potilaan oma preferenssi vaikuttaa lopputulokseen ja parantaa sitoutumista. Esimerkkinä #PTSD https://t.co/lS4pMY5qjs
Read Dr. Norah Feeny's, co-authored article "Doubly Randomized PTSD Preference Trial of Prolonged Exposure Versus Sertraline," published in the American Journal of Psychiatry! -@CWRUpsychsci https://t.co/lFTDlz2W1W @cwru @CWRUpsychsci https://t.co/6Nov1b595b
Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD | American Journal of Psychiatry https://t.co/7OSGLrcdEY
Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD | American Journal of Psychiatry https://t.co/j6pRQaqeO3
Patients with PTSD preferred prolonged exposure over sertraline (NNTB=4.5). However, both interventions showed large gains that were maintained over 24 months and no differential effect was observed on interviewer-rated PTSD severity https://t.co/Qy32jtqhN7
Client choice may affect outcome. Want to test choice vs. no choice on client outcomes? https://t.co/GulOCUPWrp
@sternentheater @spektrum_de @ABSG_DE @depr_liga Hier der Link zum @AmJPsychiatry: https://t.co/8StANWR0Yg
@LLocock @jimgthornton @GillMoncrieff @Stroppybrunette @yvkoff @TomPettinger @SaraDonetto @KatsuyamaSarah @BerksMaternity @millihill @ProsserSnelling @LindAlliance @elizabethduff2 @DrSMcMullen @Marianfknight @MaryNewburn1 Just for fun - recent paper from a clinical field I’m more familiar with - patient preference predicted treatment response https://t.co/q9sUNCFBbP These are important issues to consider but they don’t, imo, mean trials should not be done.
Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD | American Journal of Psychiatry https://t.co/6beaTXjEp8 Demonstrates that giving patients their preferred evidence based treatment improves adherence and outcomes
doi: 10.1176/appi.ajp.2013.12081133 Villarreal, G., Hamner, M. B., Canive ... doi: 10.1136/bmj.d549 appi.ajp.2018.17090995. Rothbaum, B. O., Killeen ...
https://doi.org/10.1176/appi.ajp.2018.17090995 for treatment and prevention of posttraumatic stress disorder in African Americans. Behavioral Sciences, 4(2) ...
https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2018.17090995. Share this article. Medically reviewed by Kendra Kubala, PsyD ...
2018;doi:10.1176/appi.ajp.2018.17090995. Healio AI. Ask a clinical question and tap into Healio AI's knowledge base. PubMed, enrolling ...
American Journal of Psychiatry, 2018; appi.ajp.2018.1 DOI: 10.1176/appi.ajp.2018.17090995. Fuente:ScienceDaily. Relacionado. El ejercicio ...
Original Study DOI: 10.1176/appi.ajp.2018.17090995. Related. Exercise and meditation ease PTSD after sexual assault · Horseback riding therapy ...
American Journal of Psychiatry, 2018; appi.ajp.2018.1 DOI: 10.1176/appi.ajp.2018.17090995. Cite This Page: MLA; APA; Chicago. University of ...
CA
C
IR
DH
PH
FC
P
B
H